DarshanTalks Podcast
En podcast av Darshan Kulkarni
Kategorier:
372 Avsnitt
-
Empower the Disenfranchised With Community: An Interview With Tim Styer
Publicerades: 2021-01-14 -
Brexit & COVID Approvals: An Interview With Nirpal Virdee
Publicerades: 2021-01-12 -
Inhaled Insulin and Diabetes Costs: An Interview With Pharma CEO Michael Castagna
Publicerades: 2021-01-08 -
Enabling Diversity in Biotech: Interview with Tia Lyles-Williams
Publicerades: 2020-12-17 -
SMOs and Opportunities: Interview With Dan Sfera
Publicerades: 2020-12-10 -
COVID Vaccines and the Early Approvals: An Interview With Site Expert Maria Chester
Publicerades: 2020-12-08 -
Incubators and Accelerators: Interviewing Kate & Julia
Publicerades: 2020-12-01 -
What a Clinical Trial Transparency Program Is (and Why You Need One)
Publicerades: 2020-11-24 -
Getting Health Insurance as an Entrepreneur: An Interview With Health Law Expert Kenneth White
Publicerades: 2020-11-19 -
Clinical Trial Transparency Strategy: 6 Things to Consider
Publicerades: 2020-11-17 -
How the FDA Conducts a Clinical Trial Inspection: An Interview With Former FDA Inspector Patrick Stone
Publicerades: 2020-11-12 -
6 Components of a Clinical Trial Transparency Program
Publicerades: 2020-11-06 -
Starting a Clinical Research Site: An Interview With Kelly Willenberg
Publicerades: 2020-10-29 -
Clinical Trials and Death: An Interview With Bioethicist Peter Koch
Publicerades: 2020-10-22 -
When Do I Need My First Trademark: An Interview With Donna Tobin
Publicerades: 2020-10-15 -
HIPAA and Digital Health Mistakes: An Interview With Shannon Hartsfield
Publicerades: 2020-10-08 -
MHRA’s Developing Impact on Transparency: An Interview With Nirpal Virdee
Publicerades: 2020-10-02 -
Diversity in the Biosciences – An Interview With Tia Lyles-Williams, MRSc
Publicerades: 2020-09-25 -
What Verily’s Reinsurance Platform Means for Healthcare: An Interview With Kenneth White
Publicerades: 2020-09-18 -
Transparency
Publicerades: 2020-09-08
Welcome to DarshanTalks! We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there! Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do. We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career.
